Cogora: The Agency – March digest
Our Cogora: The Agency team have had an extremely busy month, working across several different therapy areas.
The beginning of the month came with two conferences: the World Meeting of Sexual Medicine (WMSM) and the International Society of Gynecological Endocrinology (ISGE), providing insights from numerous talks, which the team summarised into digestible take-home messages for their client to share internally for those who could not attend.
We have also been busy preparing materials for the European Congress of Endocrinology (ECE), including creating speaker bios, a designed pre-congress email, a push notification, and a flyer. The team are looking forward to receiving the speaker slides, which they will prepare for medical review by applying consistent branding and generating reference packs.
Cogora: The Agency have also been busy conducting qualitative KOL interviews, going on to run two successful roundtables. These focused on the use of probiotics for antibiotic-associated diarrhoea and on women’s health. Reports are now in preparation to summarise the key insights and proposed next steps.
Furthermore, the team have been working hard conducting a systematic review on metastatic uveal melanoma – a rare type of cancer. We have successfully completed the abstract screening process, working through over 500 papers and having perfect alignment between our two reviewers.
The Agency team have also been busy finalising their patient, primary care, and secondary care infographic series, covering alopecia areata (AA) and atopic dermatitis (AD). A white paper and a peer-reviewed manuscript, covering the results of a year-long Delphi workstream, have been approved by key stakeholders are in the process of publication, with the white paper published on Healthcare Leader and the peer-reviewed manuscript awaiting decision from Skin Health and Disease.
Check out what the team were up to in February for more examples of how Cogora: The Agency delivers consistent value for its clients. For more information, please contact us.